| Accession Number | 0001632901-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 27, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Medical Officer | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 105 | $229.39 | $24,085.95 | 105 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Jan 27, 2026 | Sale | 105 | $532.61 | $55,924.05 | 0 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 125 | $208.90 | $26,112.50 | 125 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Jan 27, 2026 | Sale | 125 | $532.61 | $66,576.25 | 0 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 125 | $0.00 | $0.00 | 251 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 105 | $0.00 | $0.00 | 1,362 | Direct | โ | View Details |